Cargando…

Buccal localization of Crohn’s disease with long-term infliximab therapy: a case report

INTRODUCTION: Cheilitis granulomatosa causes persistent idiopathic lip swelling and ulceration and it can sometimes be recognized as a unique or early manifestation of Crohn’s disease. Spontaneous remission is rare and with the lack of controlled trials, different therapeutic approaches have been us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciacci, Carolina, Bucci, Cristina, Zingone, Fabiana, Iovino, Paola, Amato, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265509/ https://www.ncbi.nlm.nih.gov/pubmed/25433368 http://dx.doi.org/10.1186/1752-1947-8-397

Ejemplares similares

Tooth Wear Is Frequent in Adult Patients with Celiac Disease
por: Amato, Massimo, et al.
Publicado: (2017)

Coeliac disease: no difference in milk and dairy products consumption in comparison with controls
por: Zingone, Fabiana, et al.
Publicado: (2019)

Factors Predicting the Adherence to the Therapy of Italian IBD Patients
por: Bucci, Cristina, et al.
Publicado: (2017)

Life Events and the Onset of Celiac Disease from a Patient’s Perspective
por: Ciacci, Carolina, et al.
Publicado: (2013)

25-Hydroxyvitamin D, 1,25-Dihydroxyvitamin D, and Peripheral Bone Densitometry in Adults with Celiac Disease
por: Ciacci, Carolina, et al.
Publicado: (2020)

The Celiac Disease Patients' Ability to Experience Pleasure
por: Zingone, Fabiana, et al.
Publicado: (2019)

Prevalence of Sleep Bruxism in IBD Patients and Its Correlation to Other Dental Disorders and Quality of Life
por: Bucci, C., et al.
Publicado: (2018)

Loss of Response to Long-Term Infliximab Therapy in Children with Crohn’s Disease
por: Gouldthorpe, Oliver, et al.
Publicado: (2013)

Commentary on the article: Are hepatitis B virus and celiac disease linked?: HBV and celiac disease
por: Zingone, Fabiana, et al.
Publicado: (2011)

The Perceived Social Burden in Celiac Disease
por: Ciacci, Carolina, et al.
Publicado: (2015)

Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort Study
por: Barberio, Brigida, et al.
Publicado: (2020)

Infliximab trough level combined with inflammatory biomarkers predict long-term endoscopic outcomes in Crohn’s disease under infliximab therapy
por: Cao, Wan-Ting, et al.
Publicado: (2022)

Appetite and Gastrointestinal Hormone Response to a Gluten-Free Meal in Patients with Coeliac Disease
por: Vitaglione, Paola, et al.
Publicado: (2019)

Infliximab in the treatment of Crohn’s disease
por: Poggioli, Gilberto, et al.
Publicado: (2007)

Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn’s Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab
por: Sorrentino, Dario, et al.
Publicado: (2015)

siRNA Delivery for Control of Cyclin D1 and E2F1 Expression in Crohn’s Disease
por: Russo, Ilaria, et al.
Publicado: (2018)

siRNA Delivery for Control of Cyclin D1 and E2F1 Expression in Crohn’s Disease
por: Russo, Ilaria, et al.
Publicado: (2018)

Prevalence of Eating Disorders in Adults with Celiac Disease
por: Passananti, V., et al.
Publicado: (2013)

New Onset of Constipation during Long-Term Physical Inactivity: A Proof-of-Concept Study on the Immobility-Induced Bowel Changes
por: Iovino, Paola, et al.
Publicado: (2013)

Metastatic Crohn’s disease despite infliximab therapy
por: Campos, Sara, et al.
Publicado: (2017)

Infliximab therapy in pediatric Crohn’s disease: a review
por: Parashette, Kalyan Ray, et al.
Publicado: (2010)

Anti-NMDAR encephalitis in Crohn’s disease undergoing long-term infliximab treatment: A case report
por: Oh, Shin Ju, et al.
Publicado: (2022)

The Psychosocial Burden of HCV Infection and the Impact of Antiviral Therapy on the Quality of Life in Liver and Kidney Transplant Recipients: A Pilot Study
por: Santonicola, Antonella, et al.
Publicado: (2020)

Long-Term Clinical Outcomes of Korean Patient With Crohn's Disease Following Early Use of Infliximab
por: Kim, Nam Hee, et al.
Publicado: (2014)

Clinical and Psychological Impact of COVID-19 Infection in Adult Patients with Eosinophilic Gastrointestinal Disorders during the SARS-CoV-2 Outbreak
por: Savarino, Edoardo Vincenzo, et al.
Publicado: (2020)

Multiple liver abscesses in Crohn’s disease in infliximab therapy, successfully treated with antibiotic therapy
por: Otheo, Enrique, et al.
Publicado: (2019)

Short-Term Outcome of Infliximab Therapy in Pediatric Crohn's Disease: A Single-Center Experience
por: Jung, Dai, et al.
Publicado: (2017)

Early intestinal obstruction after infliximab therapy in Crohn’s disease
por: Chiba, Mitsuro, et al.
Publicado: (2019)

Brain Abscesses in Crohn’s Disease as a Complication of Infliximab Therapy
por: Mansour, Mahmoud M, et al.
Publicado: (2021)

Infliximab to treat Crohn’s disease: an update
por: Cottone, M, et al.
Publicado: (2011)

Early Infliximab Yields Superior Long-Term Effects on Linear Growth in Pediatric Crohn’s Disease Patients
por: Choi, Jaeyoung, et al.
Publicado: (2018)

Telemedicine in the COVID-19 era for Liver Transplant Recipients: an Italian lockdown area experience
por: Santonicola, Antonella, et al.
Publicado: (2021)

Development of pulmonary sarcoidosis in Crohn’s disease patient under infliximab biosimilar treatment after long-term original infliximab treatment: a case report and literature review
por: Kashima, Shin, et al.
Publicado: (2021)

Early Infliximab Trough Levels Predict the Long-term Efficacy of Infliximab in a Randomized Controlled Trial in Patients with Active Crohn’s Disease Comparing, between CT-P13 and Originator Infliximab
por: Park, Jihye, et al.
Publicado: (2023)

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
por: Vande Casteele, Niels, et al.
Publicado: (2015)

Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn's Disease
por: Gomes, Luis Eduardo Miani, et al.
Publicado: (2019)

Long-Term Clinical Remission in Biologically Naïve Crohn's Disease Patients with Adalimumab Therapy, Including Analyses of Switch from Adalimumab to Infliximab
por: Mizoshita, Tsutomu, et al.
Publicado: (2016)

B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy
por: Timmermans, Wilhelmina M. C., et al.
Publicado: (2016)

Intestinal fibrosis is associated with lack of response to Infliximab therapy in Crohn's disease
por: de Bruyn, Jessica R., et al.
Publicado: (2018)

Large Bowel Progressive Stricture after Infliximab Therapy for Crohn's Disease
por: Matsueda, Katsunori, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_11v9k96p8cqkb8vq1sc7t5tfte